Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study
Abstract Background Staphylococcal species account for more than 50% of periprosthetic joint infections (PJI) and antimicrobial therapy with rifampin-based combination regimens has been shown effective. The present study evaluates the safety and efficacy of clindamycin in combination with rifampin f...
Main Authors: | Borg Leijtens, Joris B. W. Elbers, Patrick D. Sturm, Bart Jan Kullberg, Berend W. Schreurs |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-017-2429-2 |
Similar Items
-
Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance
by: Ali Darwich, et al.
Published: (2021-09-01) -
Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial
by: Øystein Espeland Karlsen, et al.
Published: (2020-08-01) -
Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India
by: Pal N, et al.
Published: (2010-01-01) -
Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis
by: J. Lourtet-Hascoët, et al.
Published: (2016-10-01) -
Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified?
by: Nora Renz, et al.
Published: (2021-02-01)